Inhibrx Biosciences INBX
NASDAQ INBX
$90.61 -1.13 (-1.23%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2026)

Updated

Inhibrx Biosciences' Tax Provisions was $3,000 in Q2 2026, up 50.0% from $2,000 a year earlier.

Analysis

Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Inhibrx Biosciences' Tax Provisions was $5,000 through Jun 30, 2026, up 150.0% year-over-year; for FY2025, it was $2,000, unchanged from FY2024.

  • In earlier years, Tax Provisions was $2,000 in FY2024 (-33.3%) and $3,000 in FY2023.
  • The Q2 2026 figure marks the highest quarterly Tax Provisions since Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 1.96 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -176.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 609.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 492.00 Mn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.01 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 291.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 822.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 634.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 134.00 Mn
10 Inhibrx Biosciences 1.45 Bn 882.42 Mn - 3,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,000.00
Jun 30, 2025 2,000.00
Jun 30, 2024 2,000.00
Dec 31, 2023 -4,000.00
Sep 30, 2023 2,000.00
Jun 30, 2023 5,000.00
API Access

Inhibrx Biosciences Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=INBX&period=max&api_key=YOUR_API_KEY